Evaluation of conventional troponin I testing for the detection of myocardial dysfunction in children
Eimear McGovern1, Christine Voss1, Nicole M Hemphill1
1Division of Cardiology, Department of Pediatrics, British Columbia Children's Hospital, Vancouver, British Columbia.
Insights
Troponin I testing in children shows low sensitivity for detecting myocardial dysfunction, indicating limited utility as a screening tool for myocardial injury in this population.
Area of Science:
- Pediatric Cardiology
- Biomarkers in Cardiovascular Disease
- Pediatric Critical Care Medicine
Background:
- Troponin is a key biomarker for myocardial injury, but its role in pediatric populations is not extensively studied.
- Assessing myocardial dysfunction in children requires accurate diagnostic tools.
Purpose of the Study:
- To determine the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of troponin I for detecting acute myocardial dysfunction in previously healthy children.
- To identify clinical predictors of myocardial dysfunction in pediatric patients with elevated troponin levels.
Main Methods:
- A retrospective chart review was conducted at a single pediatric tertiary care center over a 4-year period.
- Data collected included demographics, symptoms, clinical signs, chest X-ray, ECG, and echocardiogram findings for all admitted children who underwent troponin testing.
- Myocardial dysfunction was defined based on cardiac assessment, echocardiography, and patient re-presentation.
Main Results:
- Of 566 children tested, troponin was elevated in 6.7% (38 cases), and myocardial dysfunction was detected in 1.6% (9 cases).
- Troponin I demonstrated a sensitivity of 66% and a specificity of 94% for detecting myocardial dysfunction.
- The positive predictive value (PPV) was 16%, and the negative predictive value (NPV) was 99%. An abnormal ECG was associated with true positive troponin results.
Conclusions:
- Troponin I testing identified a small number of pediatric myocardial dysfunction cases, with a sensitivity of 66%.
- The low sensitivity and PPV suggest that troponin testing has limited utility as a routine screen for myocardial injury in children.
- Further research may be needed to explore alternative biomarkers or diagnostic strategies for pediatric myocardial dysfunction.
Objectives:
Troponin is a marker of myocardial injury but is not well studied in children. Our primary objective was to ascertain the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of conventional troponin I for the detection of acute myocardial dysfunction in previously healthy children. Our secondary objective was to identify clinical predictors of myocardial dysfunction in the setting of elevated troponin.
Study Design:
This was a retrospective chart review in a single, paediatric, tertiary care centre of troponin tests performed in all admitted children over a 4-year period. Demographics, symptoms, signs, chest x-ray, ECG, and echocardiogram abnormalities were documented. Myocardial dysfunction was presumed to be absent when the patient had a normal cardiac assessment, with or without echocardiography, and did not re-present.
Results:
From January 2014 through December 2017, 566 patients had troponin tested as a screen for myocardial injury. Troponin was positive in 38 of 566 cases (6.7%). Myocardial dysfunction was detected in 9 of 566 cases (1.6%). Troponin was elevated in six of nine cases of myocardial dysfunction. The sensitivity of conventional troponin I for detecting acute myocardial dysfunction was 66% (95% confidence interval [CI] 30 to 93%). The specificity was 94% (95% CI 92 to 96%). PPV was 16% (95% CI 6 to 31%) and NPV 99% (95% CI 98 to 100%). An abnormal ECG was more prevalent in patients with a true positive versus a false-positive troponin result (P=0.03).
Conclusion:
Troponin testing identified few cases of myocardial dysfunction. We found the test to have only 66% sensitivity. Troponin testing as a screen for myocardial injury in children has limited utility.
More Related Videos
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
09:23Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum
Published on: December 13, 2017
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests
Dysrhythmias V: Evaluating Dysrhythmias
Imaging Studies for Cardiovascular System V: CT
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
